Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
157.9 INR | +2.91% | +5.24% | +13.69% |
May. 14 | Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy | MT |
May. 13 | Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.69% | 2.51B | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- PPLPHARMA Stock
- News Piramal Pharma Limited
- Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy